Zoetis Hit With Investor Suit Over Slowed Pet Drug Sales
Animal health company Zoetis Inc. has been hit with a proposed shareholder class action accusing it of misleading investors about its growth prospects amid rising competition and shifting trends in the...To view the full article, register now.
Already a subscriber? Click here to view full article